IM Cannabis Stock Surges as Traders Weigh Nasdaq Listing and Dilution Risks
IM Cannabis surged over 12% to $0.2610 with premarket quotes at $0.3491 amid high volume and no new company news, as investors eye risks from a recent resale-registration filing covering 17.3 million shares and Nasdaq’s $1.00 bid-price deadline; full conversion could boost shares outstanding by 306%, raising dilution concerns and potential stock pressure.